Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease

This study has been completed.
Sponsor:
Collaborators:
Levanger Hospital
Nord-Trøndelag University College
Information provided by (Responsible Party):
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT00744484
First received: August 29, 2008
Last updated: January 5, 2012
Last verified: January 2012
  Purpose

The purpose of this study is to determine whether water based or land based group training is more effective for people with COPD.


Condition Intervention
Chronic Obstructive Pulmonary Disease
Behavioral: Training in water
Behavioral: Training on land

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: A 12 Week Physical Training Programme for Patients With Chronic Obstructive Pulmonary Disease (COPD)-a Comparison of Water Based and Land Based Group Training

Resource links provided by NLM:


Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • VO2 peak [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Health related quality of life [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]

Enrollment: 22
Study Start Date: February 2008
Study Completion Date: September 2010
Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: B1
B1 - training in water
Behavioral: Training in water
45 minutes interval training in water, submaximal intensity, twice a week
Experimental: S1
S1 - training on land
Behavioral: Training on land
45 minutes interval training on land, submaximal intensity, twice a week

Detailed Description:

COPD is a more common diagnosis today compared to 20 years ago, and the group is growing fast. The suffering caused by COPD and the financial cost to society is on the increasing. The principal causes of COPD are smoking and inactivity. So far it is poorly understood wich form of exercise is the most effective in training this condition.

  Eligibility

Ages Eligible for Study:   50 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • COPD GOLD II
  • Not taking part in physical activity during the last year

Exclusion Criteria:

  • COPD GOLD I, III, IV
  • Pain in the legs that make activity difficult
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00744484

Locations
Norway
Levanger Hosp
Levanger, Nord-Trøndelag, Norway, 7600
Sponsors and Collaborators
Norwegian University of Science and Technology
Levanger Hospital
Nord-Trøndelag University College
Investigators
Study Director: Thor Naustdal, M.D. Hospital of Levanger
  More Information

Publications:
Responsible Party: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00744484     History of Changes
Other Study ID Numbers: 4.2007.679 (REK), 17117
Study First Received: August 29, 2008
Last Updated: January 5, 2012
Health Authority: Norway:National Committee for Medical and Health Research Ethics
Norway: Norwegian Social Science Data Services

Keywords provided by Norwegian University of Science and Technology:
Chronic Obstructive Pulmonary Disease
COPD
Physical group training
Water exercise
Cardiorespiratory fitness
Functional exercise capacity
Health related quality of life

Additional relevant MeSH terms:
Lung Diseases
Lung Diseases, Obstructive
Pulmonary Disease, Chronic Obstructive
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on November 20, 2014